Using a chatbot to improve HPV vaccine awareness and vaccination rates in middle school girls in China
Evaluation of Vaccine Chatbot on HPV Vaccine Awareness and Vaccination for Middle School Girls in China: a Randomized Controlled Trial and Implementation Science Study
NA · Fudan University · NCT06227689
This study is testing if a chatbot can help parents of middle school girls in China learn more about the HPV vaccine and encourage them to get their daughters vaccinated.
Quick facts
| Phase | NA |
|---|---|
| Study type | Interventional |
| Enrollment | 1800 (estimated) |
| Ages | 10 Years to 16 Years |
| Sex | Female |
| Sponsor | Fudan University (other) |
| Locations | 2 sites (Chizhou, Anhui and 1 other locations) |
| Trial ID | NCT06227689 on ClinicalTrials.gov |
What this trial studies
This interventional study evaluates the effectiveness of a vaccine chatbot designed to enhance awareness and knowledge of the HPV vaccine among parents of female junior middle school students in China. Participants in the intervention group will interact with the chatbot via WeChat, receiving immediate, validated answers to their questions about the HPV vaccine. The study aims to measure changes in vaccination rates and parental willingness to vaccinate their daughters, comparing results with a control group that does not use the chatbot. The research employs a cluster randomized design, sampling from various cities and schools to ensure diverse representation.
Who should consider this trial
Good fit: Ideal candidates for this study are parents of female junior middle school students who have not yet been vaccinated against HPV.
Not a fit: Patients who have already been vaccinated or have contraindications to the HPV vaccine will not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could significantly increase HPV vaccination rates among middle school girls in China.
How similar studies have performed: Other studies have shown success with digital health interventions for vaccine awareness, suggesting potential for this novel approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Parents of female students in middle school; * The students not vaccinated or appointed for HPV vaccination and without contraindications to HPV vaccines; * Without mental disorders or visual/reading impairments, and able to cooperate with and undergo the intervention activities; * Obtained informed consent and willing to participate in the study. Exclusion Criteria: * Students vaccinated or appointed for HPV vaccination or with any contraindication to HPV vaccines; * With mental disorders or visual/reading impairments, and unable to cooperate with and undergo the intervention activities; * Unwilling to participate.
Where this trial is running
Chizhou, Anhui and 1 other locations
- Chizhou Health Center for Disease Control and Prevention — Chizhou, Anhui, China (RECRUITING)
- Jiading District Center for Disease Control and Prevention — Shanghai, Shanghai Municipality, China (RECRUITING)
Study contacts
- Principal investigator: Zhiyuan Hou, PhD — School of Public Health，Fudan University
- Study coordinator: Zhiyuan Hou, PhD
- Email: zyhou@fudan.edu.cn
- Phone: 86+21 33563935
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: HPV Vaccine, HPV vaccine, awareness, knowledge, vaccination, vaccine confidence